Breaking News Instant updates and real-time market news.

REPH

Recro Pharma

$6.97

0.03 (0.43%)

06:12
06/12/17
06/12
06:12
06/12/17
06:12

Recro Pharma management to meet with Oppenheimer

Meeting to be held in Dallas on June 12 hosted by Oppenheimer.

  • 12

    Jun

REPH Recro Pharma
$6.97

0.03 (0.43%)

11/28/16
ROTH
11/28/16
NO CHANGE
Target $24
ROTH
Buy
Recro Pharma IV meloxicam is approvable, says Roth Capital
Roth Capital analyst Scott Henry notes that Recro Pharma announced the second positive efficacy trial for IV meloxicam to treat post-surgical acute pain, and confirmed its target for a summer 2017 NDA filing with few major hurdles likely remaining. The analyst believes IV meloxicam is approvable and could represent an alternative to opioid pain medications. Henry reiterates a Buy rating and $24 price target on the shares.
12/19/16
PIPR
12/19/16
INITIATION
Target $12
PIPR
Overweight
Recro Pharma initiated with an Overweight at Piper Jaffray
Piper Jaffray analyst David Amsellem started Recro Pharma with an Overweight rating and $12 price target. The company's injectable form of the non-steroidal anti-inflammatory drug meloxicam for post-surgical pain, N1539, has the potential to drive "transformational cash generation" over the long-term, Amsellem tells investors in a research note.
12/19/16
12/19/16
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Harley-Davidson (HOG) initiated with a Neutral at Goldman. 2. Anadarko (APC) initiated with a Buy at Ladenburg. 3. Baidu (BIDU) initiated with an Underweight at Cantor. 4. Recro Pharma (REPH) initiated with an Overweight at Piper Jaffray. 5. B&G Foods (BGS) initiated with a Neutral at Citi. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
03/07/17
ROTH
03/07/17
NO CHANGE
Target $20
ROTH
Buy
Recro Pharma price target lowered to $20 from $24 at Roth Capital
Roth Capital analyst Scott Henry lowered his price target for Recro Pharma to $20 from $24 after quarterly results. The analyst believes the company remains on target for an NDA filing for IV Meloxicam to treat acute pain this summer, and reiterates a Buy rating on the shares.

TODAY'S FREE FLY STORIES

CTL

CenturyLink

$18.90

-0.48 (-2.48%)

10:35
08/18/17
08/18
10:35
08/18/17
10:35
Options
CenturyLink put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DE

Deere

$114.63

-9.355 (-7.55%)

10:30
08/18/17
08/18
10:30
08/18/17
10:30
Hot Stocks
Deere notes material cost increases impacting margins »

The company highlighted…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Aug

  • 22

    Nov

10:30
08/18/17
08/18
10:30
08/18/17
10:30
General news
U.S. consumer sentiment surged 4.2 points to 97.6 in the August »

U.S. consumer sentiment…

TXMD

TherapeuticsMD

$6.28

0.01 (0.16%)

10:29
08/18/17
08/18
10:29
08/18/17
10:29
Hot Stocks
Analysts upbeat on TherapeuticsMD after large NIH study »

Analysts this morning…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Nov

APEI

American Public Education

$17.90

-0.05 (-0.28%)

10:28
08/18/17
08/18
10:28
08/18/17
10:28
Conference/Events
American Public Education management to meet with Barrington »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Aug

  • 24

    Aug

10:25
08/18/17
08/18
10:25
08/18/17
10:25
General news
Treasury Action: yields steadied above lows »

Treasury Action: yields…

10:25
08/18/17
08/18
10:25
08/18/17
10:25
Conference/Events
Cowen Washington strategist holds analyst/industry conference call »

Washington Research Group…

HPE

HP Enterprise

$17.11

-0.19 (-1.10%)

10:20
08/18/17
08/18
10:20
08/18/17
10:20
Options
Repeat option activity in Hewlett Packard Enterprises »

Repeat option activity in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Sep

10:20
08/18/17
08/18
10:20
08/18/17
10:20
General news
The Michigan sentiment pop to 97.6 »

The Michigan sentiment…

MDU

MDU Resources

$25.82

0.01 (0.04%)

10:18
08/18/17
08/18
10:18
08/18/17
10:18
Syndicate
Breaking Syndicate news story on MDU Resources »

MDU Resources files mixed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

10:17
08/18/17
08/18
10:17
08/18/17
10:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

10:16
08/18/17
08/18
10:16
08/18/17
10:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FOSL

Fossil

$7.77

-0.09 (-1.15%)

10:15
08/18/17
08/18
10:15
08/18/17
10:15
Options
Fossil put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:15
08/18/17
08/18
10:15
08/18/17
10:15
General news
FX Action: The dollar »

FX Action: The dollar…

AMTD

TD Ameritrade

$42.44

-0.93 (-2.14%)

10:13
08/18/17
08/18
10:13
08/18/17
10:13
Conference/Events
TD Ameritrade management to meet with Jefferies »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Aug

  • 24

    Aug

  • 06

    Sep

DE

Deere

$113.40

-10.58 (-8.53%)

10:12
08/18/17
08/18
10:12
08/18/17
10:12
Hot Stocks
Deere says long term global tail winds for agricultural economy in place »

Comments are from the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Aug

  • 22

    Nov

CTL

CenturyLink

$19.13

-0.25 (-1.29%)

, LVLT

Level 3

$52.64

-0.35 (-0.66%)

10:12
08/18/17
08/18
10:12
08/18/17
10:12
Recommendations
CenturyLink, Level 3 analyst commentary  »

CenturyLink and Level 3…

CTL

CenturyLink

$19.13

-0.25 (-1.29%)

LVLT

Level 3

$52.64

-0.35 (-0.66%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GD

General Dynamics

$197.16

-0.832 (-0.42%)

10:11
08/18/17
08/18
10:11
08/18/17
10:11
Hot Stocks
General Dynamics awarded $115.3M contract modification by Navy »

General Dynamics Electric…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Aug

10:05
08/18/17
08/18
10:05
08/18/17
10:05
General news
FX Action: USD-CAD »

FX Action: USD-CAD fell…

IWM

iShares Trust Russell 2000 Index Fund

$134.44

-0.49 (-0.36%)

, RUT

Russell 2000 Index

10:02
08/18/17
08/18
10:02
08/18/17
10:02
Technical Analysis
Technical View: Russell 2000 Index nears key technical levels »

The Russell 2000 (RUT) is…

IWM

iShares Trust Russell 2000 Index Fund

$134.44

-0.49 (-0.36%)

RUT

Russell 2000 Index

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:01
08/18/17
08/18
10:01
08/18/17
10:01
General news
Consumer Sentiment Index data reported »

Consumer Sentiment Index…

QQQ

PowerShares QQQ Trust

$141.33

-2.95 (-2.04%)

10:00
08/18/17
08/18
10:00
08/18/17
10:00
Options
Defensive spread in PowerShares QQQ »

Defensive spread in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:00
08/18/17
08/18
10:00
08/18/17
10:00
General news
Breaking General news story  »

Dallas Federal Reserve…

IMUC

ImmunoCellular

$0.32

-0.0191 (-5.65%)

09:56
08/18/17
08/18
09:56
08/18/17
09:56
Conference/Events
ImmunoCellular to host conference call »

Business News Update…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Aug

ROST

Ross Stores

$53.33

-1.04 (-1.91%)

, EL

Estee Lauder

$102.49

4.165 (4.24%)

09:55
08/18/17
08/18
09:55
08/18/17
09:55
Options
Early notable gainers among liquid option names on August 18th »

Notable gainers among…

ROST

Ross Stores

$53.33

-1.04 (-1.91%)

EL

Estee Lauder

$102.49

4.165 (4.24%)

NEM

Newmont Mining

$37.16

1.11 (3.08%)

AMAT

Applied Materials

$43.12

-1.34 (-3.01%)

XEC

Cimarex Energy

$96.89

0.59 (0.61%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Aug

  • 22

    Aug

  • 23

    Aug

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.